Needle revision outcomes after glaucoma filtering surgery: survival analysis and predictive factors. Issue 2 (March 2020)
- Record Type:
- Journal Article
- Title:
- Needle revision outcomes after glaucoma filtering surgery: survival analysis and predictive factors. Issue 2 (March 2020)
- Main Title:
- Needle revision outcomes after glaucoma filtering surgery: survival analysis and predictive factors
- Authors:
- Rabiolo, Alessandro
Marchese, Alessandro
Bettin, Paolo
Monteduro, Davide
Galasso, Mario
Dolci, Maria Paola
Di Matteo, Federico
Fiori, Marina
Ciampi, Carlo
Bandello, Francesco - Abstract:
- Purpose: To evaluate the efficacy and safety of needle revision and examine factors predictive of failure. Methods: In total, 157 eyes of 131 patients that underwent needle revision augmented with either 5-fluorouracil or betamethasone for trabeculectomy failure were included in this retrospective study. Complete failure was defined as additional glaucoma surgery, ciliodestructive procedures, loss of light perception, sight-threatening complications, hypotony maculopathy, and surgical bleb revision. Success was defined as intraocular pressure ⩽ 18 (criterion A), ⩽15 (criterion B), and ⩽12 mmHg (criterion C) reached with (qualified) or without (complete) medications, and absence of any criteria of complete failure. Results: The median (interquartile range) follow-up was 25.0 (41.0) months. Complete failure rates were 19%, 26%, and 31% at 1, 2, and 3 years, respectively. For criterion A, qualified and complete success rates were, respectively, 77% and 69% at 1 year, 66% and 51% at 2 years, and 60% and 47% at 3 years. For criterion B, qualified and complete success rates were, respectively, 67% and 61% at 1 year, 48% and 42% at 2 years, and 44% and 39% at 3 years. For criterion C, qualified and complete success rates were, respectively, 43% and 41% at 1 year, 27% and 25% at 2 years, and 24% and 23% at 3 years. High baseline intraocular pressure and primary surgery were associated with higher and lower risks of complete failure, respectively. Conclusion: Needle revision is anPurpose: To evaluate the efficacy and safety of needle revision and examine factors predictive of failure. Methods: In total, 157 eyes of 131 patients that underwent needle revision augmented with either 5-fluorouracil or betamethasone for trabeculectomy failure were included in this retrospective study. Complete failure was defined as additional glaucoma surgery, ciliodestructive procedures, loss of light perception, sight-threatening complications, hypotony maculopathy, and surgical bleb revision. Success was defined as intraocular pressure ⩽ 18 (criterion A), ⩽15 (criterion B), and ⩽12 mmHg (criterion C) reached with (qualified) or without (complete) medications, and absence of any criteria of complete failure. Results: The median (interquartile range) follow-up was 25.0 (41.0) months. Complete failure rates were 19%, 26%, and 31% at 1, 2, and 3 years, respectively. For criterion A, qualified and complete success rates were, respectively, 77% and 69% at 1 year, 66% and 51% at 2 years, and 60% and 47% at 3 years. For criterion B, qualified and complete success rates were, respectively, 67% and 61% at 1 year, 48% and 42% at 2 years, and 44% and 39% at 3 years. For criterion C, qualified and complete success rates were, respectively, 43% and 41% at 1 year, 27% and 25% at 2 years, and 24% and 23% at 3 years. High baseline intraocular pressure and primary surgery were associated with higher and lower risks of complete failure, respectively. Conclusion: Needle revision is an effective and safe procedure to rescue failing trabeculectomy postponing or avoiding further glaucoma surgery. Eyes with low target intraocular pressure may have poor long-term outcomes. … (more)
- Is Part Of:
- European journal of ophthalmology. Volume 30:Issue 2(2020)
- Journal:
- European journal of ophthalmology
- Issue:
- Volume 30:Issue 2(2020)
- Issue Display:
- Volume 30, Issue 2 (2020)
- Year:
- 2020
- Volume:
- 30
- Issue:
- 2
- Issue Sort Value:
- 2020-0030-0002-0000
- Page Start:
- 350
- Page End:
- 359
- Publication Date:
- 2020-03
- Subjects:
- Antimetabolites -- betamethasone -- filtering bleb -- needling -- trabeculectomy -- 5-fluorouracil
Ophthalmology -- Periodicals
Eye -- Diseases -- Periodicals
617.7005 - Journal URLs:
- http://www.uk.sagepub.com/home.nav ↗
http://www.eur-j-ophthalmol.com/Home/Index ↗
http://journals.sagepub.com/home/ejo ↗ - DOI:
- 10.1177/1120672119830861 ↗
- Languages:
- English
- ISSNs:
- 1120-6721
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 12773.xml